Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Secondary Sclerosing Cholangitis in Critically Ill Patients (SSC-CIP): A Pilot Study on the Possible Genetic Basis of the Disease

NCT02545309 is registered in ClinicalTrials.gov with Medical University of Graz as lead sponsor.

NCT NCT02545309
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02545309 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Secondary Sclerosing Cholangitis in Critically Ill Patients (SSC-CIP): A Pilot Study on the Possible Genetic Basis of the Disease
Lead sponsor
Medical University of Graz
Phase
Observational
Overall status
Active, not recruiting
Start date
December 21, 2015
Completion date
January 31, 2029
Enrollment
140 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

secondary sclerosing cholangitis